Melanie O'brien Matta, AUD - Medicare Audiologist in Cranberry Twp, PA

Melanie O'brien Matta, AUD is a medicare enrolled "Audiologist" provider in Cranberry Twp, Pennsylvania. Her current practice location is 301 Smith Dr Ste 5, Cranberry Twp, Pennsylvania. You can reach out to her office (for appointments etc.) via phone at (412) 709-7997.

Melanie O'brien Matta is licensed to practice in * (Not Available) (license number ) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1902977234.

Contact Information

Melanie O'brien Matta, AUD
301 Smith Dr Ste 5,
Cranberry Twp, PA 16066-4131
(412) 709-7997
Not Available



Healthcare Provider's Profile

Full NameMelanie O'brien Matta
GenderFemale
SpecialityAudiologist
Location301 Smith Dr Ste 5, Cranberry Twp, Pennsylvania
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1902977234
  • Provider Enumeration Date: 11/10/2006
  • Last Update Date: 08/30/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 7315041860
  • Enrollment ID: I20231002002974

Medical Identifiers

Medical identifiers for Melanie O'brien Matta such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1902977234NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
231H00000XAudiologist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Melanie O'brien Matta allows following entities to bill medicare on her behalf.
Provider NameHearing Boutique Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1154106896
PECOS PAC ID: 4688028129
Enrollment ID: O20231002002784

News Archive

Visualization of SARS-CoV-2 RNA by fluorescence in situ hybridization probes

A team of scientists from France has recently designed fluorescence in situ hybridization probes (CoronaFISH) to visualize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in infected cells. A detailed description of the probe design, validation, and application is currently available on the bioRxiv preprint server.

Lucideon welcomes students on 7th framework European project ‘Biodensol'

Lucideon, the international materials technology company, welcomes three international students on the 7th framework European project ‘Biodensol'. The three students involved with the project have now begun an intense training period before they embark on developing novel glass, ceramic and sol-gel powders with dental applications.

ADRCs cells improve survival in acute kidney injury animal model

Preclinical data was published today on research performed by Cytori Therapeutics (NASDAQ:CYTX) showing adipose (fat)-derived stem and regenerative cells (ADRCs), either fresh or banked, demonstrated statistically significant improvements in animal survival and kidney function in an acute kidney injury animal model.

Experimental drugs from Sanofi and Regenron cut cholesterol in a new way

An experimental drug that acts in a novel way to lower cholesterol proved even more effective than statins and had few undesirable side effects, newly released data shows. The drug acts by modifying the way cholesterol levels are naturally controlled. A protein produced in the liver helps limit the amount of LDL, or "bad" cholesterol, that liver cells can remove from the bloodstream. The new drug, called REGN727, is a monoclonal antibody, made in a laboratory, that blocks the action of that protein.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Melanie O'brien Matta is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Melanie O'brien Matta, AUD
301 Smith Dr Ste 5,
Cranberry Twp, PA 16066-4131

Ph: (412) 709-7997
Melanie O'brien Matta, AUD
301 Smith Dr Ste 5,
Cranberry Twp, PA 16066-4131

Ph: (412) 709-7997

News Archive

Visualization of SARS-CoV-2 RNA by fluorescence in situ hybridization probes

A team of scientists from France has recently designed fluorescence in situ hybridization probes (CoronaFISH) to visualize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in infected cells. A detailed description of the probe design, validation, and application is currently available on the bioRxiv preprint server.

Lucideon welcomes students on 7th framework European project ‘Biodensol'

Lucideon, the international materials technology company, welcomes three international students on the 7th framework European project ‘Biodensol'. The three students involved with the project have now begun an intense training period before they embark on developing novel glass, ceramic and sol-gel powders with dental applications.

ADRCs cells improve survival in acute kidney injury animal model

Preclinical data was published today on research performed by Cytori Therapeutics (NASDAQ:CYTX) showing adipose (fat)-derived stem and regenerative cells (ADRCs), either fresh or banked, demonstrated statistically significant improvements in animal survival and kidney function in an acute kidney injury animal model.

Experimental drugs from Sanofi and Regenron cut cholesterol in a new way

An experimental drug that acts in a novel way to lower cholesterol proved even more effective than statins and had few undesirable side effects, newly released data shows. The drug acts by modifying the way cholesterol levels are naturally controlled. A protein produced in the liver helps limit the amount of LDL, or "bad" cholesterol, that liver cells can remove from the bloodstream. The new drug, called REGN727, is a monoclonal antibody, made in a laboratory, that blocks the action of that protein.

Read more News

› Verified 7 days ago


Audiologist in Cranberry Twp, PA

Hearing Boutique, Llc
Audiologist
Medicare: Medicare Enrolled
Practice Location: 301 Smith Dr Ste 5, Cranberry Twp, PA 16066
Phone: 412-709-7997    
George H Fyke,
Audiologist
Medicare: Not Enrolled in Medicare
Practice Location: 105 Brandt Dr, Suite 201, Cranberry Twp, PA 16066
Phone: 724-772-5420    Fax: 724-772-5423
Jenna Ann Littleton,
Audiologist
Medicare: Accepting Medicare Assignments
Practice Location: 20820 Route 19 Ste A, Cranberry Twp, PA 16066
Phone: 724-779-4444    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.